Some of H1N1 flu vaccine in pre-filled syringes recall from the market caused the active ingredient ‘antigen’ showed decrease of strengthen over the time.

One of the manufacturer who recall the H1N1 product is Sanofi Pasteur.
The recall product for distribution vaccine between November 2009 until January 2010 about 1.3 million doses lots.

The manufacturer has sent instruction how to return unused vaccine to all health care provider from the affected lots bellow;

- UT023AA, UT023BA, UT023CA, UT023EA, UT023FA (NDC # 49281-650-25, which also may be recorded as # 49281-0650-25), 0.25 mL syringes in 10-packs

- UT037AA (NDC # 49281-650-90, which also may be recorded as # 49281-0650-90), 0.5 mL syringes in 25-packs

The manufacturer said, these recalled product has no correlation related to safety and re-administration.
It’s about quality assurance of the product which shows decrease of the strengthen from antigen as active ingredients.

Related posts:

1. The potential treatment options for malignant pleural mesothelioma through Vaccine Recent study try to find other mesothelioma treatment option for...
2. Pneumococcal vaccine PCV-7 may lead to serious progressive lung disease PCV7, the heptavalent pneumococcal conjugate vaccine, clearly to protect infant...
3. H1N1 Swine Flu Pandemic Who is a priority for vaccination with the H1N1 swine...
4. Estimation of H1N1 2009 cases, hospitalizations and deaths in US From the data on influenza-associated hospitalizations collected through CDC’s Emerging...
5. Warning usage of Insulin Pump device for diabetes patients therapy, possible needle detachement during injection! Many diabetes patients (usually diabetes mellitus) using alternative therapy treatment...

Visitor Guidance :::MOUSE OVER YOUR POINTER TO THE HOMEOPATHIC AND NATURAL IMAGE PRODUCTS FOR SHORT PRODUCTS DESCRIPTION (YOUR JAVASCRIPT BROWSER MUST BE ENABLE) OR SEE IN ABOVE SUB-CATEGORIES::: Return to HOMEPAGE.